Biomind Labs Inc.
BMND
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.08% | -1.94% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.22% | -1.99% | |||
| Operating Income | 16.22% | 1.99% | |||
| Income Before Tax | 83.73% | -13.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 83.73% | -13.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 83.73% | -13.91% | |||
| EBIT | 16.22% | 1.99% | |||
| EBITDA | 16.65% | 1.94% | |||
| EPS Basic | 85.71% | -12.00% | |||
| Normalized Basic EPS | 83.33% | -12.50% | |||
| EPS Diluted | 85.71% | -12.00% | |||
| Normalized Diluted EPS | 83.33% | -12.50% | |||
| Average Basic Shares Outstanding | 3.62% | 0.00% | |||
| Average Diluted Shares Outstanding | 3.62% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||